Diabetes Mellitus, Type 1
"Diabetes Mellitus, Type 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Descriptor ID |
D003922
|
| MeSH Number(s) |
C18.452.394.750.124 C19.246.267 C20.111.327
|
| Concept/Terms |
Diabetes Mellitus, Type 1- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Brittle
- Brittle Diabetes Mellitus
- Diabetes Mellitus, Insulin-Dependent
- Diabetes Mellitus, Insulin Dependent
- Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Juvenile-Onset
- Diabetes Mellitus, Juvenile Onset
- Juvenile-Onset Diabetes Mellitus
- Diabetes Mellitus, Ketosis-Prone
- Diabetes Mellitus, Ketosis Prone
- Ketosis-Prone Diabetes Mellitus
- Juvenile-Onset Diabetes
- Diabetes, Juvenile-Onset
- Juvenile Onset Diabetes
- Diabetes Mellitus, Type I
- Diabetes Mellitus, Sudden-Onset
- Diabetes Mellitus, Sudden Onset
- Mellitus, Sudden-Onset Diabetes
- Sudden-Onset Diabetes Mellitus
- Type 1 Diabetes Mellitus
- Diabetes Mellitus, Insulin-Dependent, 1
- Insulin-Dependent Diabetes Mellitus 1
- Insulin Dependent Diabetes Mellitus 1
- Type 1 Diabetes
- Diabetes, Type 1
- IDDM
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 1".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 1".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 1" by people in this website by year, and whether "Diabetes Mellitus, Type 1" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 10 | 2 | 12 | | 1997 | 4 | 4 | 8 | | 1998 | 8 | 2 | 10 | | 1999 | 17 | 2 | 19 | | 2000 | 12 | 5 | 17 | | 2001 | 9 | 2 | 11 | | 2002 | 17 | 2 | 19 | | 2003 | 22 | 3 | 25 | | 2004 | 42 | 5 | 47 | | 2005 | 34 | 2 | 36 | | 2006 | 25 | 6 | 31 | | 2007 | 36 | 3 | 39 | | 2008 | 40 | 9 | 49 | | 2009 | 62 | 8 | 70 | | 2010 | 51 | 8 | 59 | | 2011 | 63 | 4 | 67 | | 2012 | 56 | 7 | 63 | | 2013 | 80 | 7 | 87 | | 2014 | 81 | 6 | 87 | | 2015 | 84 | 3 | 87 | | 2016 | 66 | 4 | 70 | | 2017 | 94 | 9 | 103 | | 2018 | 109 | 8 | 117 | | 2019 | 119 | 6 | 125 | | 2020 | 131 | 8 | 139 | | 2021 | 114 | 4 | 118 | | 2022 | 136 | 3 | 139 | | 2023 | 111 | 2 | 113 | | 2024 | 104 | 6 | 110 | | 2025 | 95 | 4 | 99 | | 2026 | 43 | 0 | 43 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 1" by people in Profiles.
-
Karakus KE, Clayton MG, Baschal EE, McDaniel KA, Yu L, Haider Z, Polsky S, Akturk HK, Gottlieb PA, Garg SK, Michels AW. Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes. Diabetes Care. 2026 07 01; 49(7):1194-1201.
-
Hohsfield KR, Carry P, Slack S, Repaci CT, Vanderlinden LA, Kechris K, Rewers M, Norris JM, Johnson RK. Differences in immune cell profiles around the time of islet autoimmunity seroconversion in children with and without type 1 diabetes. BMJ Open Diabetes Res Care. 2026 May 25; 14(3).
-
Wright EE, Low Wang CC, Novak LM, Shubrook JH. Misclassification of type 1 diabetes as type 2 diabetes in adults: practical guidance for screening and diagnosis for primary care providers. Postgrad Med. 2026 May; 138(4):396-407.
-
Ciccaglione M, Abenojar E, Kosmides T, DiLisio JE, McDaniel KA, Hartmoore K, Gresch A, Jarrell DK, Ramirez DG, Sticco-Ivins M, Michels AW, Haskins K, Exner AA, Benninger RKP. Submicron-sized ultrasound contrast agents as therapeutic peptide delivery vehicles in type 1 diabetes. Theranostics. 2026; 16(12):6692-6712.
-
Bluestone JA, Herold KC, Sussel L. Type 1 Diabetes: Advances in Understanding and Treatment 100 Years after the Discovery of Insulin. Cold Spring Harb Perspect Med. 2026 05 01; 16(5).
-
Karakus KE, Akturk HK, Kruger D, Ahmann A, Bharvaga A, Langel CR, Ackeifi CA, Rosen J, Pyle L, Snell-Bergeon JK, Shah VN. Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis. Diabetes Care. 2026 May 01; 49(5):718-723.
-
Carry PM, Kim S, Zwick NL, Buckner T, DeFelice B, Johnson RK, Seifert J, Waugh K, Dong F, Vanderlinden LA, Frohnert BI, Kechris K, Fiehn O, Rewers M, Norris JM. Increased Levels of the Vitamin D Metabolite Ratio Are Protective Against Progression From Islet Autoimmunity to T1D. J Clin Endocrinol Metab. 2026 Apr 22; 111(5):1438-1449.
-
Seget S, Rusak E, Pelicand J, Fry M, Sheanon N, Schierloh U, Xatzipsalti M, Malinici E, Tinti D, Neylon O, Bazdarska Y, Cobry E, Hauser E. Automated insulin delivery use in children and adolescents with type 1 diabetes across the world. Diabetes Res Clin Pract. 2026 Jun; 236:113253.
-
Rønn PF, Svensson J, Wibaek R, Dabelea D, Hulman A. HbA1c trajectories and risk of albuminuria in children and adolescents with type 1 diabetes followed into adulthood - a joint modeling approach of Danish nationwide register data. J Diabetes Complications. 2026 May; 40(5):109317.
-
DiLisio JE, Beard KS, Neef T, Miller SD, Wenzlau JM, Nakayama M, D'Antonio MA, Jamison BL, Nicholson KS, Baker RL, Brunetti TM, Gapin L, Haskins K. Antigen-specific immunotherapy with a CD4+ T cell neoepitope restrains CD8+ T cell differentiation in murine pancreatic islet grafts. Nat Commun. 2026 Mar 24; 17(1).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|